These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 1179878

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Changes in the antigenicity of influenza virus neuraminidases due to various methods of preparation].
    Desselberger U.
    Fortschr Med; 1978 Mar 09; 96(9):471-6. PubMed ID: 627393
    [Abstract] [Full Text] [Related]

  • 7. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep 09; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 8. Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus.
    Couch RB.
    Dev Biol Stand; 1975 Sep 09; 28():295-306. PubMed ID: 1126573
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
    Robuccio JA, Griffith JW, Chroscinski EA, Cross PJ, Light TE, Lang CM.
    Lab Anim Sci; 1995 Aug 09; 45(4):420-6. PubMed ID: 7474883
    [Abstract] [Full Text] [Related]

  • 10. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H.
    Acta Virol; 1973 Jul 09; 17(4):287-92. PubMed ID: 4148207
    [No Abstract] [Full Text] [Related]

  • 11. [Contribution to the antigenic study of influenza viruses in animals. II.--Antibodies, antineuraminidase in horse: conditions of apparition and importance (author's transl)].
    Fontaine M, Fontaine M.
    Ann Rech Vet; 1975 Jul 09; 6(4):411-20. PubMed ID: 1231622
    [Abstract] [Full Text] [Related]

  • 12. Serological response to an adsorbed killed trivalent influenza vaccine (including A/New Jersey 8/76 antigen).
    Sarateanu D, Ehrengut W, Pressler K.
    Dev Biol Stand; 1975 Jul 09; 39():235-8. PubMed ID: 604102
    [Abstract] [Full Text] [Related]

  • 13. Kinetics of reactions of antihemagglutinin and antineuraminidase antibodies with H2N2 and H3N2 influenza virus strains and description of a modification of the photometric ACU method for titration of antineuraminidase antibodies.
    Drescher J, Desselberger U.
    Arch Virol; 1976 Jul 09; 50(1-2):97-107. PubMed ID: 1259594
    [Abstract] [Full Text] [Related]

  • 14. [Tolerance and immunogenicity of an attenuated live influenza virus vaccine in man (author's transl)].
    Kuwert E, Höher PG, Fröcher R, Marcus I, Thraenhart O.
    Dtsch Med Wochenschr; 1975 Dec 26; 100(52):2629-35. PubMed ID: 1204500
    [Abstract] [Full Text] [Related]

  • 15. [Influenza vaccination in dialysis patients].
    Haldimann B, Descoeudres C.
    Schweiz Med Wochenschr; 1978 Jan 14; 108(2):52-5. PubMed ID: 622534
    [Abstract] [Full Text] [Related]

  • 16. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
    Hehme N, Engelmann H, Kuenzel W, Neumeier E, Saenger R.
    Virus Res; 2004 Jul 14; 103(1-2):163-71. PubMed ID: 15163505
    [Abstract] [Full Text] [Related]

  • 17. [Antibody response to trivalent anti-influenza vaccination (inactivated virus) A/Texas/1/77 H3N2), A/URSS/90/77 (H1N1), B/Hong Kong/8/73].
    Mancini G, Andreoni M, Arangio-Ruiz G, Sarrecchia C, Donatelli I, Resta S, Rozera C, Sordillo P, Rocchi G.
    Boll Ist Sieroter Milan; 1982 May 14; 61(2):85-91. PubMed ID: 7126342
    [Abstract] [Full Text] [Related]

  • 18. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
    Kilbourne ED, Cerini CP, Khan MW, Mitchell JW, Ogra PL.
    J Immunol; 1987 May 01; 138(9):3010-3. PubMed ID: 3571981
    [Abstract] [Full Text] [Related]

  • 19. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E, Munster VJ, Spronken MI, Bestebroer TM, Baas C, Beyer WE, Rimmelzwaan GF, Osterhaus AD, Fouchier RA.
    J Virol; 2005 Oct 01; 79(19):12401-7. PubMed ID: 16160167
    [Abstract] [Full Text] [Related]

  • 20. Differences in antibody responses of mice to intranasal or intraperitoneal immunization with influenza A virus and vaccination with subunit influenza vaccine.
    Fislová T, Sládková T, Gocník M, Mucha V, Varecková E, Kostolanský F.
    Acta Virol; 2005 Oct 01; 49(4):243-50. PubMed ID: 16402681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.